Synovial inflammation and bone metabolism
PRINCIPAL INVESTIGATORS
- José Antonio Narváez García
- Juan Miguel Nolla Sole
- Francisco Javier Juanola Roura
- Antonio Rozadilla Sacanell
- Carmen Gómez Vaquero
- Laura Berbel Arcobe
- Diego Benavent Nuñez
CLINICAL RESEARCHERS
- José Antonio Narváez García
- Juan Miguel Nolla Sole
- Francisco Javier Juanola Roura
- Antonio Rozadilla Sacanell
- Carmen Gómez Vaquero
- Laura Berbel Arcobe
- Diego Benavent Nuñez
SCIENTIFIC SUPPORT
- Daniel Fontes Carame
Translational Medicine
Cardiovascular, Respiratory and Systemic Diseases and cellular aging
Scientific production
41
PAPERS
Average IF: 5,73
20
LED PAPERS
Average IF: 5,75
5 PUBLICATIONS IN FIRST DECILE
30 PUBLICATIONS IN FIRST QUARTILE
28 PUBLICATIONS IN OPEN ACCESS
Selected publications
- Benavent,D;Navarro Compán,V, Exploring the latest advances in axial spondyloarthritis management, Nat Rev Rheumatol, 2024;20(2):69-70, doi:10.1038/s41584-023-01072-7
- Aouad,K;de Wit,M;Elhai,M;Benavent,D;Bertheussen,H;Zabalan,C;Primdahl,J et al, Patient research partner involvement in rheumatology research: a systematic literature review informing the 2023 updated EULAR recommendations for the involvement of patient research partners, Ann Rheum Dis, 2024;83(10):1268-1277, doi:10.1136/ard-2024-225567
- de Wit,M;Aouad,K;Elhai,M;Benavent,D;Bertheussen,H;Blackburn,S;Böhm,P et al, EULAR recommendations for the involvement of patient research partners in rheumatology research: 2023 update, Ann Rheum Dis, 2024;83(11):1443-1453, doi:10.1136/ard-2024-225566
- Nárvaez,J;Aguilar Coll,M;Roig Kim,M;Maymó Paituvi,P;Palacios Olid,J;Nolla,JM;Llop,D, Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis, Autoimmun Rev, 2024;23(10):103636-103636, doi:10.1016/j.autrev.2024.103636
- Benavent,D;Benavent Núñez,M;Marin Corral,J;Arias Manjón,J;Navarro Compán,V;Taberna,M;Salcedo,I et al, Natural language processing to identify and characterize spondyloarthritis in clinical practice, RMD Open, 2024;10(2):doi:10.1136/rmdopen-2024-004302
Research highlights
PROJECTS
2 Ongoing competitive projects
11 Started clinical trials
16 Ongoing clinical trials
PUBLISHED WORKS
3 Clinical Guidelines
2 Theses
Selected projects
- 202022-30. Design of an integrative patients stratification approach for the systemic sclerosis management. Fundació La Marató de TV3. Budget: 162.020,53€. 2021-2024. PI: NARVAEZ GARCIA, FRANCISCO JAVIER.
- AP176692021. Caracterización del eStroMa inflAmatoRio en meTástasis ósEas de cáncer de próstata resistente a castración utilizando técnicas de secuenciación de células individuales y correlación con diferentes patrones radiómicos utilizando Resonancia magnética de dif. Fundación Mutua Madrileña (FMM), AYUDAS A LA INVESTIGACIÓN EN SALUD 2019. Budget: 150.000€. 2021-2025. PI: Narváez García, José Antonio / Piulats Rodríguez, Josep María.
- 2022-501421-20-00. A Randomized, Multi-regional, Double-blind, Double-dummy Parallel-group, Placebo and Allopurinol-controlled Phase 3 Study to Assess the Efficacy and Safety of Tigulixostat in Gout Patients with Hyperuricemia. LG Chem, Ltd. Budget: 102.877,65€. 2024-2025. PI: CARMEN MORAGUES PASTOR.
- 2023-504022-19. A Multicenter, Parallel-group, Double-blind, 2-Arm, Phase III Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared with Placebo Added to Standard of Care in Adult Participants with Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis). AstraZeneca AB. Budget: 41.118,9€. 2024- . PI: PAOLA VIDAL MONTAL.
- RES-6136-C1. ENSAYO CLÍNICO MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO PARA EVALUAR LA EFICACIA Y SEGURIDAD DE UNA COMBINACIÓN BASADA EN PALMITOILETANOLAMIDA (PEA) EN LA SINTOMATOLOGÍA DE LA ARTROSIS DE RODILLA. ESTUDIO ARTROPEA.. ITF RESEARCH PHARMA,S.L.U.. Budget: 8.000€. 2025- . PI: CARMEN MORAGUES PASTOR.